F. Fruzzetti

发表

G. Palla, F. Fruzzetti, T. Fidecicchi, 2021 .

Discontinuation of modern hormonal contraceptives: an Italian survey

A. Gadducci, F. Bucci, F. Fruzzetti, 2016, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS)

A. Gadducci, F. Bucci, F. Fruzzetti, 2017, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Comparison of PCOS phenotypes in adolescent and young adult Mediterranean women with possible PCOS

E. Carmina, G. Palla, F. Fruzzetti, 2020, Journal of Endocrinological Investigation.

Long-term treatment with α-lipoic acid and myo-inositol positively affects clinical and metabolic features of polycystic ovary syndrome

M. Gambacciani, G. Palla, F. Fruzzetti, 2019, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Clinical and Metabolic Effects of Alpha-Lipoic Acid Associated with Two Different Doses of Myo-Inositol in Women with Polycystic Ovary Syndrome

M. Tonacchera, E. Benelli, F. Fruzzetti, 2020, International journal of endocrinology.

Clinical and endocrine effects of flutamide in hyperandrogenic women.

P. Fioretti, D. de Lorenzo, F. Fruzzetti, 1993, Fertility and sterility.

21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study.

V. Rohmer, D. Pignatelli, R. Azziz, 2000, American journal of obstetrics and gynecology.

Clinical and metabolic effects of a triphasic pill containing gestodene.

I. Nicoletti, P. Fioretti, F. Fruzzetti, 1992, Contraception.

Clinical and metabolic effects of a pill containing 30 mcg ethinylestradiol plus 75 mcg gestodene.

M. Cerri, P. Fioretti, G. Melis, 1989, Contraception.

Features of polycystic ovary syndrome (PCOS) in women with functional hypothalamic amenorrhea (FHA) may be reversible with recovery of menstrual function

R. Lobo, E. Carmina, F. Fruzzetti, 2018, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Increased anti-Mullerian hormone levels and ovarian size in a subgroup of women with functional hypothalamic amenorrhea: further identification of the link between polycystic ovary syndrome and functional hypothalamic amenorrhea.

R. Lobo, E. Carmina, F. Fruzzetti, 2016, American journal of obstetrics and gynecology.

Hormone replacement therapy in perimenopausal women with a low dose oral contraceptive preparation: effects on bone mineral density and metabolism.

P. Fioretti, B. Cappagli, S. Maffei, 1994, Maturitas.

Clinical characteristics and genetic analysis in women with premature ovarian insufficiency.

A. Pinchera, P. Vitti, E. Pucci, 2013, Maturitas.

Insulin resistance and hyperandrogenism have no substantive association with birth weight in adolescents with polycystic ovary syndrome.

A. Fulghesu, F. Fruzzetti, R. Manca, 2015, Fertility and sterility.

Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels.

A. Genazzani, F. Fruzzetti, D. Perini, 2009, Fertility and sterility.

Oral contraceptives and venous thromboembolic disease: the effect of the oestrogen dose.

P. Fioretti, G. Melis, F. Fruzzetti, 1988, Maturitas.

Role of progestins with partial antiandrogenic effects

J. Hanker, R. Sitruk-Ware, J. Huber, 2004, Climacteric : the journal of the International Menopause Society.

Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism.

G. Morgante, V. de Leo, M. C. Musacchio, 2013, Contraception.

Effect of aging on clinical features and metabolic complications of women with polycystic ovary syndrome

E. Pucci, M. Tonacchera, A. Molinaro, 2021, Journal of Endocrinological Investigation.

Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women

A. Genazzani, S. Taddei, A. Salvetti, 2003, Journal of hypertension.

The impact of estrogen on adrenal androgen sensitivity and secretion in polycystic ovary syndrome.

R. Lobo, L. Chang, F. Fruzzetti, 1995, The Journal of clinical endocrinology and metabolism.

Insulin resistance causes impaired vasodilation and hypofibrinolysis in young women with polycystic ovary syndrome.

C. Giannarelli, G. Dell'omo, R. Pedrinelli, 2005, Thrombosis research.

Estro-progestin Contraceptives and Risk of Cervical Cancer: A Debated Issue

A. Gadducci, S. Cosio, F. Fruzzetti, 2020, AntiCancer Research.

Treatment with d-chiro-inositol and alpha lipoic acid in the management of polycystic ovary syndrome

S. Lello, F. Fruzzetti, A. Capozzi, 2019, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Activation of coagulation in smoking and non-smoking women using a third-generation oral contraceptive containing desogestrel.

A. Genazzani, F. Fruzzetti, F. De Negri, 1999, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Endogenous digitalis-like factor in pregnant and non-pregnant women.

P. Fioretti, G. Melis, A. Clerico, 1988, The Journal of nuclear medicine and allied sciences.

Pill, depression and suicide: a never-ending story of myth and reality

M. Neri, G. Capobianco, F. Fruzzetti, 2020, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

The use of combined hormonal contraceptives amid the COVID-19 pandemic. Reply

A. Cagnacci, F. Fruzzetti, 2020, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Inhibitory effect of the dopamine agonist bromocriptine on the postcastration gonadotrophin rise in women.

P. Fioretti, G. Melis, V. Mais, 1981, The Journal of clinical endocrinology and metabolism.

Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome.

A. Genazzani, M. Gambacciani, F. Fruzzetti, 2010, Fertility and sterility.

Adolescents with Classical Polycystic Ovary Syndrome Have Alterations in the Surrogate Markers of Cardiovascular Disease but Not in the Endothelial Function. The Possible Benefits of Metformin.

A. Gadducci, C. Giannarelli, L. Ghiadoni, 2016, Journal of pediatric and adolescent gynecology.

Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects.

A. Genazzani, F. Fruzzetti, D. Parrini, 1999, Fertility and sterility.

Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density.

A. Genazzani, M. Gambacciani, M. Ciaponi, 2006, Maturitas.

Oral Contraceptives and Venous Thromboembolism

S. Shapiro, J. Verhaeghe, D. Seidman, 2010, Journal of Family Planning and Reproductive Health Care.

Oral Contraceptives and Venous Thromboembolism-Consensus Opinion from an International Workshop held in Berlin, Germany in December 2009

S. Shapiro, J. Verhaeghe, D. Seidman, 2010 .

Workshop Participants/ Consensus Opinion Contributors

S. Shapiro, J. Verhaeghe, D. Seidman, 2010 .

Germany in December 2009 an International Workshop held in Berlin , Thromboembolism : Consensus Opinion from Oral Contraceptives and Venous

S. Shapiro, J. Verhaeghe, D. Seidman, 2010 .

A 12-month clinical investigation with a 24-day regimen containing 15 μg ethinylestradiol plus 60 μg gestodene with respect to hemostasis and cycle control

A. Genazzani, F. Fruzzetti, F. Carmassi, 2001 .

Original research article A 12-month clinical investigation with a 24-day regimen containing 15 mg ethinylestradiol plus 60 mg gestodene with respect to hemostasis and cycle control

A. Genazzani, F. Fruzzetti, F. Carmassi, 2001 .

Haemostasis profile in smoking and nonsmoking women taking low-dose oral contraceptives.

P. Fioretti, F. Fruzzetti, C. Ricci, 1994, Contraception.

A comparative study on the effects of a monophasic pill containing desogestrel plus 20 micrograms ethinylestradiol, a triphasic combination containing levonorgestrel and a monophasic combination containing gestodene on coagulatory factors.

I. Nicoletti, P. Fioretti, G. Melis, 1991, Contraception.

Fibrinopeptide A plasma levels during low-estrogen oral contraceptive treatment.

P. Fioretti, G. Melis, A. Paoletti, 1984, Contraception.

Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia.

V. Rohmer, F. Keleştimur, D. Pignatelli, 2007, The Journal of clinical endocrinology and metabolism.

P. Fioretti, G. Melis, V. Mais, 1982 .

An overview of the development of combined oral contraceptives containing estradiol: focus on estradiol valerate/dienogest

J. Bitzer, F. Trémollieres, F. Fruzzetti, 2012, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Review of clinical experience with estradiol in combined oral contraceptives.

J. Bitzer, F. Fruzzetti, 2010, Contraception.

A multicenter study of women with nonclassical congenital adrenal hyperplasia: relationship between genotype and phenotype.

R. Azziz, E. Knochenhauer, D. Dewailly, 2000, Molecular genetics and metabolism.

Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea

F. Petraglia, S. Luisi, A. Genazzani, 2001, The Journal of Steroid Biochemistry and Molecular Biology.

Ovarian influence on adrenal androgen secretion in polycystic ovary syndrome.

D. de Lorenzo, G. Teti, F. Fruzzetti, 1995, Fertility and sterility.

High testosterone levels of ovarian origin affect adrenal steroidogenesis?

P. Fioretti, G. Melis, V. Mais, 1991, The Journal of clinical endocrinology and metabolism.

Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome.

A. Genazzani, F. Fruzzetti, D. Parrini, 2002, Fertility and sterility.

A COMPARATIVE STUDY ON THE EFFECTS OF A MONOPRASIC PILL CONTAINING DESOGESTRRL PLUS 20 pg ETHINYLRSTRADIOL, A TRIPRASIC COMRINATION CONTAINING LRVONORGESTRRL AND A MONOPFIASIC COMBINATION CONTAINING GESTODENR ON COAGULATORY FACTORS

I. Nicoletti, P. Fioretti, P. Lammers, 1991 .

Attitudes of Italian women concerning suppression of menstruation with oral contraceptives

A. Paoletti, A. Genazzani, M. Lombardo, 2008, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Venous thrombosis and hormonal contraception: what’s new with estradiol-based hormonal contraceptives?

A. Cagnacci, F. Fruzzetti, 2018, Open access journal of contraception.

Aminophylline treatment of preterm labor.

P. Fioretti, G. Melis, C. Cipolloni, 1984, Acta Europaea fertilitatis.

Serum thyrotropin by ultrasensitive immunoradiometric assay and serum free thyroid hormones in pregnancy

A. Pinchera, L. Bartalena, E. Martino, 1986, Journal of endocrinological investigation.

The role of Inositols in PCOS – Opinion Paper

L. Fedele, S. Salomone, F. Drago, 2019 .

COVID-19, gender and estroprogestins, what do we know?

F. Fruzzetti, T. Fidecicchi, J. Calaf, 2021, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Hormonal Contraception and Depression: Updated Evidence and Implications in Clinical Practice

F. Fruzzetti, T. Fidecicchi, 2020, Clinical Drug Investigation.

Characterization of a novel mutation V136L in bone morphogenetic protein 15 identified in a woman affected by POI

P. Agretti, M. Tonacchera, T. Simoncini, 2021, Journal of Ovarian Research.

Unilateral adnexal agenesis and dermoid cyst: fertility implications

A. Gadducci, F. Bucci, F. Fruzzetti, 2015, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Platelet-vessel Wall Interactions with Third-generation Oral Contraceptives: No Evidence of Detrimental Effects

R. de Caterina, R. Puntoni, W. Bernini, 1999, Thrombosis and Haemostasis.

Norethisterone enanthate as an injectable contraceptive in puerperal and non-puerperal women.

P. Fioretti, G. Melis, B. Düsterberg, 1981, Contraception.

Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome

F. Keleştimur, R. Norman, C. Zouboulis, 2012, Endocrine.

AMH MEASUREMENT VERSUS OVARIAN ULTRASOUND IN THE DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME IN DIFFERENT PHENOTYPES.

R. Lobo, E. Carmina, F. Fruzzetti, 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Pharmacological activation of gamma-aminobutyric acid-system blunts prolactin response to mechanical breast stimulation in puerperal women.

P. Fioretti, G. Melis, V. Mais, 1984, The Journal of clinical endocrinology and metabolism.

EFFECTS OF THE GABAERGIC DRUG, SODIUM VALPROATE, ON THE PROLACTIN RELEASE EVOKED BY PHARMACOLOGICAL STIMULI IN NORMAL WOMEN

G. Trimarchi, P. Fioretti, V. Mais, 1984, Clinical endocrinology.

The effects of the gabaergic drug, sodium valproate, on prolactin secretion in normal and hyperprolactinemic subjects.

A. Paoletti, P. Fioretti, G. Melis, 1982, The Journal of clinical endocrinology and metabolism.

Beyaz®: An Oral Contraceptive Fortified with Folate

F. Fruzzetti, 2012, Women's health.

Metabolic effects of three new low-dose pills: a six-month experience.

P. Fioretti, G. Melis, R. Navalesi, 1989, Contraception.

Hyperandrogenemia influences the prevalence of the metabolic syndrome abnormalities in adolescents with the polycystic ovary syndrome

A. Genazzani, F. Fruzzetti, D. Perini, 2009, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Contraception with estradiol valerate and dienogest: adherence to the method

A. Paoletti, M. Gambacciani, R. Giannini, 2019, Open Access Journal of Contraception.

NOMAC-E2 shows a better contraceptive effectiveness than LNG combined oral contraceptives in women under 25: real-world PRO-E2 study.

K. Becker, C. Keck, A. Bauerfeind, 2023, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

The oral contraceptive containing 30 microg of ethinylestradiol plus 3 mg of drospirenone is able to antagonize the increase of extracellular water occurring in healthy young women during the luteal phase of the menstrual cycle: an observational study.

A. Paoletti, A. Genazzani, R. Sorge, 2007, Contraception.

Bone metabolism in young women taking a monophasic pill containing 20 mcg ethinylestradiol: a prospective study.

A. Paoletti, S. Guerriero, S. Ajossa, 1993, Contraception.

Vaginal treatment with a prostaglandin F2 alpha derivative (alfaprostol) for inducing labor in pregnancy at term.

P. Fioretti, G. Melis, F. Fruzzetti, 1987, Prostaglandins.

Use of Sulprostone for Induction of Preoperative Cervical Dilation or Uterine Evacuation: A Comparison Among the Effects of Different Treatment Schedules

P. Fioretti, G. Melis, F. Strigini, 1988, Obstetrics and gynecology.

Tailored hormonal approach in women with premature ovarian insufficiency

T. Simoncini, M. Gambacciani, G. Palla, 2020, Climacteric : the journal of the International Menopause Society.

Estetrol: A New Choice for Contraception

T. Simoncini, F. Fruzzetti, T. Fidecicchi, 2021, Journal of clinical medicine.

How often is oral contraception used for contraception? The need of benefit’s formalisation

A. Cagnacci, V. Bruni, F. Fruzzetti, 2023, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

NOMAC-E2 compares to LNG combined oral contraceptives in women over forty: real-world PRO-E2 study.

K. Becker, C. Keck, A. Bauerfeind, 2023, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Effect of an oral contraceptive containing 30 microg ethinylestradiol plus 3 mg drospirenone on body composition of young women affected by premenstrual syndrome with symptoms of water retention.

A. Paoletti, A. Genazzani, M. Gambacciani, 2007, Contraception.

Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome.

M. Rizzo, K. Berneis, E. Carmina, 2007, The Journal of clinical endocrinology and metabolism.

TREATMENT OF HIRSUTISM : COMPARISONS BETWEEN DIFFERENT ANTIANDROGENS WITH CENTRAL AND PERIPHERAL EFFECTS

A. Genazzani, F. Fruzzetti, D. Parrini, 1999 .

Ultrasound in polycystic ovary syndrome--the measuring of ovarian stroma and relationship with circulating androgens: results of a multicentric study.

A. Lanzone, S. Angioni, G. B. Melis, 2007, Human reproduction.

Hemostatic effects of smoking and oral contraceptive use.

F. Fruzzetti, 1999, American journal of obstetrics and gynecology.

Clinical and metabolic study of a new pill containing 20 mcg ethinylestradiol plus 0.150 mg desogestrel.

M. Cerri, P. Fioretti, G. Melis, 1987, Contraception.

Effects of finasteride, a 5 alpha-reductase inhibitor, on circulating androgens and gonadotropin secretion in hirsute women.

D. de Lorenzo, F. Fruzzetti, D. Parrini, 1994, The Journal of clinical endocrinology and metabolism.

Observational prospective study on Lactobacillus plantarum P 17630 in the prevention of vaginal infections, during and after systemic antibiotic therapy or in women with recurrent vaginal or genitourinary infections

F. Parazzini, V. de Leo, E. Cicinelli, 2018, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

Ovarian volume in normal and hyperandrogenic adolescent women.

E. Carmina, F. Fruzzetti, D. Perini, 2015, Fertility and sterility.

The use of 16,16‐dimethyl‐trans‐Δ2 prostaglandin E1 methyl ester vaginal suppositories for management of missed abortion and fetal death

L. De Cecco, A. Genazzani, P. Fioretti, 1991, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Contraception during Coronavirus-Covid 19 pandemia. Recommendations of the Board of the Italian Society of Contraception

M. Guida, C. Nappi, A. Paoletti, 2020, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.